Abstract:A simple and general method in the synthesis of N-alkoxycarbonyl ketimines derived from isatins has been described first. Generally, the enantioselective addition of 1,3-dicarbonyl compounds to this kind of ketimine affords chiral 3-amino oxindoles in high yield and excellent ee.
“…Recently, a significant advance has been achieved in the development of synthetic methodologies for these targets; These methods include organocatalytic and metal-catalyzed asymmetric α-amination, 5 chiral auxiliary-controlled diastereoselective synthesis of chiral 3-substituted 3-aminooxindoles 6 and enantioselective additions of isatin-derived ketimines. 7 Very recently, Wang and co-workers reported the asymmetric addition of 1,3-dicarbonyl compounds onto N -alkoxycarbonyl ketimines and asymmetric aza -Friedel-Craft reaction of indoles and pyrroles with N -Boc ketimines in the presence of chiral phosphoric acid catalysts; 8 the latter led to the formation of 3-aminooxindoles in good yields with excellent enantioselectivities. 9 …”
Asymmetric catalytic aza-Morita-Baylis-Hillman (aza-MBH) reaction of isatin-derived ketimines with MVK has been established by using chiral amino and phosphino catalysts. The reaction resulted in biomedically important 3-substituted 3-amino-2-oxindoles in good yields (>80% for most cases) and excellent enantioselectivity (90–99%ee). Twenty-eight cases assembled with chiral quaternary stereogenic centers have been examined under convenient systems.
“…Recently, a significant advance has been achieved in the development of synthetic methodologies for these targets; These methods include organocatalytic and metal-catalyzed asymmetric α-amination, 5 chiral auxiliary-controlled diastereoselective synthesis of chiral 3-substituted 3-aminooxindoles 6 and enantioselective additions of isatin-derived ketimines. 7 Very recently, Wang and co-workers reported the asymmetric addition of 1,3-dicarbonyl compounds onto N -alkoxycarbonyl ketimines and asymmetric aza -Friedel-Craft reaction of indoles and pyrroles with N -Boc ketimines in the presence of chiral phosphoric acid catalysts; 8 the latter led to the formation of 3-aminooxindoles in good yields with excellent enantioselectivities. 9 …”
Asymmetric catalytic aza-Morita-Baylis-Hillman (aza-MBH) reaction of isatin-derived ketimines with MVK has been established by using chiral amino and phosphino catalysts. The reaction resulted in biomedically important 3-substituted 3-amino-2-oxindoles in good yields (>80% for most cases) and excellent enantioselectivity (90–99%ee). Twenty-eight cases assembled with chiral quaternary stereogenic centers have been examined under convenient systems.
“…Commercially available isatins were used as received. N-protected isatins 1 were prepared as described in the literature [42]. (2R,3S)-1-benzyl-3-hydroxy-3-methylindoline-2-carbonitrile (4a): TMSCN (37 µL, 0.294 mmol) was added dropwise on a solution of 3a (0.1 mmol) in CH 2 Cl 2 (2 mL) at room temperature under nitrogen.…”
Chiral α-hydroxyamide L5 derived from (S)-(+)-mandelic acid catalyzes the enantioselective addition of dimethylzinc to isatins affording the corresponding chiral 3-hydroxy-3-methyl-2-oxindoles with good yields and er up to 90:10. Furthermore, several chemical transformations were performed with the 3-hydroxy-2-oxindoles obtained.
“…100 The range of imines accessible by this procedure was extended by Yan and coworkers, 101 who used various azaphosphoranes as starting materials (Scheme 41).…”
In this review we generalize and analyze information about reactions between isatin and three-, four-, and five-coordinate phosphorus compounds, published between 1966 and 2014. Ph 3 P COOR P O OR OR O Me P H O RO RO
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.